Deguelin as a chemopreventive agent in mouse lung tumorigenesis induced by tobacco smoke carcinogens

Journal of the National Cancer Institute

Volumn 97, Issue 22, 2005, Pages 1634-1635

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 2 PHENETHYL ISOTHIOCYANATE; 3 PHENYLPROPYL ISOTHIOCYANATE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; BUTYLATED HYDROXYANISOLE; DEGUELIN; INOSITOL; N ACETYL S (N 2 PHENETHYLTHIOCARBAMOYL)CYSTEINE; PROTEIN KINASE B; ROTENONE; SULFORAPHANE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

CARDIOTOXICITY; CIGARETTE SMOKING; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; EDITORIAL; GENE ACTIVATION; GOVERNMENT REGULATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG INJURY; NONHUMAN; PARKINSONISM; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATION DEPRESSION; SKIN IRRITATION; SMOKING CESSATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; NITROSAMINES; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY MUCOSA; ROTENONE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 27944469148     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji414     Document Type: Editorial

References (28)

1. Lee HY, Oh SH, Woo JK, Kim WY, Van Pelt CS, Price RE, et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst 2005;97:1695-9.
2. Hecht SS, Isaacs S, Trushin N. Lung tumor induction in A/J mice by the tobacco smoke carcinogens (4-methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: A potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 1994;15:2721-5.
3. Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol, and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 1999;137:123-30.
4. Hecht SS, Kenney PM, Wang M, Upadhyaya P. Dose-response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butane. Cancer Lett 2000;167:1-6.
5. Hecht SS, Kenney PM, Wang W, Trushin N, Upadhyaya P. Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett 1999;150: 49-56.
6. Hecht SS, Upadhyaya P, Wang M, Bliss RL, McIntee EJ, Kenney PM. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositiol, individually and in combination. Carcinogenesis 2002;23:1455-61.
7. Conaway CC, Wang CX, Pittman B, Yang YM, Schwartz JE, Tian D, et al. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 2005;65:8548-57.
8. Prokopczyk B, Rosa JG, Desai D, Amin S, Sohn OS, Fiala ES, et al. Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Lett 2000;161:35-46.
9. Hecht SS. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ Health Perspect 1997;105 Suppl 4:955-63.
10. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
11. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW. Effect of chemopreventive agents on separate stages of progression of benzo[a]pyrene induced lung tumors in A/J mice. Carcinogenesis 2004;25:197-201.
12. Wattenberg L, Wiedmann T, Estensen R, Zimmermann C, Steele V, Kelloff G. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 2000;21:179-82.
13. Wattenberg LW, Estensen RD. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 1996;56:5132-5.
14. Witschi H. A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: Strengths and weaknesses. Exp Lung Res 2005;31:3-18.
15. Stinn W, Teredesai A, Kuhl P, Knorr-Wittmann C, Kindt R, Coggins C, et al. Mechanisms involved in A/J mouse lung tumorigenesis induced by inhalation of an environmental tobacco smoke surrogate. Inhal Toxicol 2005;17:263-76.
16. Hecht SS. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: Old and new. Carcinogenesis 2005;26:1488-92.
17. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
18. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, et al. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis 2005 Jun 30; [Epub ahead of print].
19. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003;111:81-90.
20. Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, et al. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol 2004;17:1540-8.
21. Budavari S, editor. The Merck Index: An encyclopedia of chemicals, drugs, and biologicals, 12 ed. Whitehouse Station (NJ): Merck & Co; 1996. p. 484.
22. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
23. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2003. MMWR Morb Mortal Wkly Rep 2005;54: 509-13.
24. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon (France): IARC; 2004. p. 97-9.
25. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2000.
26. Joseph AM, Hennrikus D, Thoele MJ, Krueger R, Hatsukami D. Community tobacco control leaders' perceptions of harm reduction. Tob Control 2004;13:108-13.
27. Blot WJ, Fraumeni JF Jr. Cancers of the lung and pleura. In: D Schottenfeld, J Fraumeni. Cancer epidemiology and prevention. New York (NY): Oxford University Press; 1996. p. 637-65.
28. van Zandwijk N. Chemoprevention in lung carcinogenesis - an overview. Eur J Cancer 2005;41:1990-2002.